• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m A 甲基化在与年龄相关的疾病的细胞衰老中。

m A methylation in cellular senescence of age-associated diseases.

机构信息

Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin 541100, China.

The Fifth Affiliated Hospital of Southern Medical University, Guangzhou 510900, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2023 Jul 3;55(8):1168-1183. doi: 10.3724/abbs.2023107.

DOI:10.3724/abbs.2023107
PMID:37394885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10449638/
Abstract

Cellular senescence is a state of irreversible cellular growth arrest that occurs in response to various stresses. In addition to exiting the cell cycle, senescent cells undergo many phenotypic alterations, including metabolic reprogramming, chromatin rearrangement, and senescence-associated secretory phenotype (SASP) development. Furthermore, senescent cells can affect most physiological and pathological processes, such as physiological development; tissue homeostasis; tumour regression; and age-associated disease progression, including diabetes, atherosclerosis, Alzheimer's disease, and hypertension. Although corresponding anti-senescence therapies are actively being explored for the treatment of age-associated diseases, the specific regulatory mechanisms of senescence remain unclear. N -methyladenosine (m A), a chemical modification commonly distributed in eukaryotic RNA, plays an important role in biological processes such as translation, shearing, and RNA transcription. Numerous studies have shown that m A plays an important regulatory role in cellular senescence and aging-related disease. In this review, we systematically summarize the role of m A modifications in cellular senescence with regard to oxidative stress, DNA damage, telomere alterations, and SASP development. Additionally, diabetes, atherosclerosis, and Alzheimer's disease regulation via m A-mediated cellular senescence is discussed. We further discuss the challenges and prospects of m A in cellular senescence and age-associated diseases with the aim of providing rational strategies for the treatment of these age-associated diseases.

摘要

细胞衰老(Cellular senescence)是一种细胞在受到各种压力后不可逆的生长停滞状态。除了退出细胞周期外,衰老细胞还会经历许多表型改变,包括代谢重编程、染色质重排和衰老相关分泌表型(SASP)的发展。此外,衰老细胞可以影响大多数生理和病理过程,如生理发育、组织稳态、肿瘤消退以及与年龄相关的疾病进展,包括糖尿病、动脉粥样硬化、阿尔茨海默病和高血压。尽管针对与年龄相关的疾病的抗衰老治疗正在积极探索,但衰老的具体调节机制仍不清楚。N6 -甲基腺苷(m A)是一种普遍存在于真核 RNA 中的化学修饰,在翻译、剪切和 RNA 转录等生物学过程中发挥着重要作用。大量研究表明,m A 在细胞衰老和与衰老相关的疾病中起着重要的调节作用。在这篇综述中,我们系统地总结了 m A 修饰在氧化应激、DNA 损伤、端粒改变和 SASP 发展等方面对细胞衰老的作用。此外,还讨论了 m A 介导的细胞衰老对糖尿病、动脉粥样硬化和阿尔茨海默病的调节作用。我们进一步讨论了 m A 在细胞衰老和与年龄相关的疾病中的挑战和前景,旨在为这些与年龄相关的疾病的治疗提供合理的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60c/10449638/cbbc0bc3ebf6/abbs-2023-036-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60c/10449638/a6ad4c77ef1a/abbs-2023-036-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60c/10449638/cbbc0bc3ebf6/abbs-2023-036-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60c/10449638/a6ad4c77ef1a/abbs-2023-036-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60c/10449638/cbbc0bc3ebf6/abbs-2023-036-t2.jpg

相似文献

1
m A methylation in cellular senescence of age-associated diseases.m A 甲基化在与年龄相关的疾病的细胞衰老中。
Acta Biochim Biophys Sin (Shanghai). 2023 Jul 3;55(8):1168-1183. doi: 10.3724/abbs.2023107.
2
Mechanisms and functions of cellular senescence.细胞衰老的机制和功能。
J Clin Invest. 2018 Apr 2;128(4):1238-1246. doi: 10.1172/JCI95148.
3
METTL3-mediated mA modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression.METTL3 介导的 ATG7 的 mA 修饰调节自噬-GATA4 轴促进细胞衰老和骨关节炎进展。
Ann Rheum Dis. 2022 Jan;81(1):87-99. doi: 10.1136/annrheumdis-2021-221091. Epub 2021 Oct 27.
4
[Cellular senescence and age-related diseases].[细胞衰老与年龄相关疾病]
Rinsho Ketsueki. 2019;60(9):1027-1032. doi: 10.11406/rinketsu.60.1027.
5
Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.控制衰老分泌组:对衰老相关分泌表型的分子调控
Exp Gerontol. 2016 Sep;82:39-49. doi: 10.1016/j.exger.2016.05.010. Epub 2016 May 25.
6
Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases.细胞外囊泡作为衰老相关分泌表型的新兴作用:对肺部疾病病理生理学的认识。
Mol Aspects Med. 2018 Apr;60:92-103. doi: 10.1016/j.mam.2017.11.005. Epub 2017 Nov 20.
7
The role of cellular senescence and SASP in tumour microenvironment.细胞衰老和 SASP 在肿瘤微环境中的作用。
FEBS J. 2023 Mar;290(5):1348-1361. doi: 10.1111/febs.16381. Epub 2022 Feb 20.
8
Genes and pathways involved in senescence bypass identified by functional genetic screens.通过功能遗传筛选鉴定涉及衰老旁路的基因和途径。
Mech Ageing Dev. 2021 Mar;194:111432. doi: 10.1016/j.mad.2021.111432. Epub 2021 Jan 8.
9
Time-dependent replicative senescence vs. disturbed flow-induced pre-mature aging in atherosclerosis.动脉粥样硬化中时间依赖性复制性衰老与紊乱血流诱导的过早衰老
Redox Biol. 2020 Oct;37:101614. doi: 10.1016/j.redox.2020.101614. Epub 2020 Jun 24.
10
Cellular senescence and the senescent secretory phenotype in age-related chronic diseases.细胞衰老和与年龄相关的慢性疾病中的衰老分泌表型。
Curr Opin Clin Nutr Metab Care. 2014 Jul;17(4):324-8. doi: 10.1097/MCO.0000000000000065.

引用本文的文献

1
METTL3-mediated m A modification of pri-miRNA-31 promotes hypertrophic scar progression.METTL3介导的初级微小RNA-31的N⁶-甲基腺苷修饰促进增生性瘢痕进展。
Acta Biochim Biophys Sin (Shanghai). 2025 Mar 18;57(7):1106-1114. doi: 10.3724/abbs.2025033.
2
RNA m6A methylation regulatory mechanism of resveratrol in premature senescence cells.白藜芦醇在早衰细胞中的RNA m6A甲基化调控机制
Food Sci Nutr. 2024 Sep 30;12(11):9238-9251. doi: 10.1002/fsn3.4487. eCollection 2024 Nov.
3
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson's Disease.

本文引用的文献

1
RNA m6A methylation across the transcriptome.RNA m6A 甲基化在转录组中的分布。
Mol Cell. 2023 Feb 2;83(3):428-441. doi: 10.1016/j.molcel.2023.01.006.
2
Dynamic regulation and key roles of ribonucleic acid methylation.核糖核酸甲基化的动态调控及关键作用
Front Cell Neurosci. 2022 Dec 19;16:1058083. doi: 10.3389/fncel.2022.1058083. eCollection 2022.
3
IL-17A promotes endothelial cell senescence by up-regulating the expression of FTO through activating JNK signal pathway.白细胞介素-17A通过激活JNK信号通路上调FTO的表达,从而促进内皮细胞衰老。
环境表观转录组学和 RNA 修饰在帕金森病中的新兴作用。
J Parkinsons Dis. 2024;14(4):643-656. doi: 10.3233/JPD-230457.
4
Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.解析 2 型糖尿病的表观遗传学机制:发病机制与治疗意义。
Front Endocrinol (Lausanne). 2024 Jan 22;15:1295967. doi: 10.3389/fendo.2024.1295967. eCollection 2024.
Biogerontology. 2023 Feb;24(1):99-110. doi: 10.1007/s10522-022-09999-2. Epub 2022 Dec 3.
4
Downregulation of the mA reader protein YTHDC1 leads to islet β-cell failure and diabetes.mA 读码蛋白 YTHDC1 的下调导致胰岛 β 细胞衰竭和糖尿病。
Metabolism. 2023 Jan;138:155339. doi: 10.1016/j.metabol.2022.155339. Epub 2022 Oct 24.
5
Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis.mRNA 中 N6-甲基腺苷的特征分析及 METTL3 在动脉粥样硬化中的功能研究。
Cells. 2022 Sep 24;11(19):2980. doi: 10.3390/cells11192980.
6
Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice.分析 MPTP 诱导的帕金森病小鼠黑质和纹状体中的 m6A 修饰调节因子。
Neurosci Lett. 2022 Nov 20;791:136907. doi: 10.1016/j.neulet.2022.136907. Epub 2022 Oct 7.
7
Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification.RNA m6A 甲基化调控因子在阿尔茨海默病发生发展中的新作用及亚型分类
Int J Mol Sci. 2022 Sep 15;23(18):10766. doi: 10.3390/ijms231810766.
8
Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.骨质疏松症中 m6A 相关分子模式与诊断生物标志物的综合分析
Front Endocrinol (Lausanne). 2022 Aug 10;13:957742. doi: 10.3389/fendo.2022.957742. eCollection 2022.
9
Epigenetic regulation in intervertebral disc degeneration.椎间盘退变中的表观遗传调控。
Trends Mol Med. 2022 Oct;28(10):803-805. doi: 10.1016/j.molmed.2022.07.007. Epub 2022 Aug 24.
10
Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe mice.线粒体靶向瑞香素通过调节 SIRT1 介导的血管细胞衰老和 Apoe 小鼠中线粒体功能来减轻衰老背景下的动脉粥样硬化。
Atherosclerosis. 2022 Sep;356:28-40. doi: 10.1016/j.atherosclerosis.2022.07.012. Epub 2022 Jul 20.